Source: Citybizlist

Abzena: Abzena Appoints Dr Moncef Slaoui to Board

SAN DIEGO, Jan. 8, 2025 /PRNewswire/ - Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the... Read MoreThe post Abzena Appoints Dr Moncef Slaoui to Board appeared first on citybiz.

Read full article »

Abzena's Competitors | Abzena's News | Abzena's Financials

Followers on Owler

1,376

Est. Annual Revenue

$5.0-25M

Est. Employees

250-500

CEO

Matthew Stober

CEO Approval Rating

82/100

Abzena is an England-based contract research organization that offers services such as antibody discovery and drug conjugate development for the biopharmaceutical sector.